Rizatriptan Benzoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 21 USDMF, 12 CEP/COS, 4 JDMF, 18 EU WC, 14 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

13 API Suppliers

13 API Suppliers

FINISHED DOSAGE FORMULATIONS

301 FDF Dossiers, 55 FDA Orange Book, 160 Europe, 38 Canada, 6 Australia, 17 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 6 Rochem International Inc, 18 SPI Pharma, 5 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 16 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 3 Actylis, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 NEWEDGE Overseas, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 6 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 42 Direct Compression, 27 Taste Masking, 23 Thickeners and Stabilizers, 23 Controlled & Modified Release, 23 Granulation, 22 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 17 Film Formers & Plasticizers, 16 Co-Processed Excipients, 9 Parenteral, 9 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Solubilizers, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 2 Topical, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 160 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20865 / DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
rizatriptan benzoate(UNII: WR978S7QHH) (rizatriptan - UNII:51086HBW8G)	rizatriptan	5mg \| 10mg \| 5mg \| 10mg

Inactive Ingredients

Ingredient Name	Merck Sharp & Dohme Corp.	Par Pharmaceutical Inc.
aspartame(Z0H242BBR1)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERRIC OXIDE RED(1K09F3G675)
gelatin(2G86QN327L)
gelatin, unspecified(2G86QN327L)
glycine(TE7660XO1C)
lactose monohydrate(EWQ57Q8I5X)
magnesium stearate(70097M6I30)
mannitol(3OWL53L36A)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
STARCH, CORN(O8232NY3SJ)

Drug Product Composition: Rizatriptan Benzoate